MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 217558 shares changing hands. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The firm’s fifty day simple moving average is C$0.07 and its 200 day simple moving average is C$0.07. The company has a market capitalization of C$25.25 million, a PE ratio of -2.00 and a beta of 0.31. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10.
MediPharm Labs (TSE:LABS – Get Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported C($0.01) earnings per share for the quarter. MediPharm Labs had a negative net margin of 30.56% and a negative return on equity of 24.41%. The company had revenue of C$11.45 million for the quarter. On average, research analysts predict that MediPharm Labs Corp. will post -0.04 EPS for the current year.
About MediPharm Labs
MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.
Read More
- Five stocks we like better than MediPharm Labs
- Where Do I Find 52-Week Highs and Lows?
- Why Gold Loves Trump as Much as Trump Loves Gold
- 3 Warren Buffett Stocks to Buy Now
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
